2. In an experimental study, researchers are testing a new flea preventive medication on dogs using a blind study. Dogs are treated with the new medication or with a placebo. Who should know which dogs are given the medication or the placebo for this blind study?
Answer: A
Neither the researchers nor the dog owners nor the response gatherers should know which dogs are given the medication or the placebo.
In a blind study, it is crucial that neither the participants nor the researchers involved in data collection are aware of which group (medication or placebo) the subjects belong to, to prevent bias in the results.
A) Neither the researchers nor the dog owners nor the response gatherers
This option is correct because in a blind study, the aim is to eliminate any potential bias that might arise from knowing which dogs receive the medication or the placebo. Keeping all parties in the dark regarding group allocation helps ensure the integrity of the data collected and the validity of the study's findings.
B) Only the researchers
This option is incorrect as it suggests that the researchers could know which dogs received the treatment while the dog owners and response gatherers do not. This could lead to unintentional bias in how the researchers interact with the dogs or interpret the results, undermining the study's objectivity.
C) The researchers, the dog owners, and the response gatherers
This option is incorrect because if all parties are aware of the treatment assignments, it would compromise the study's blind design. Knowledge of which dogs received the medication or placebo could influence their perceptions and behaviors, thereby skewing the results and reducing the reliability of the study.
D) Only the dog owners
This option is also incorrect, as allowing dog owners to know which dogs received the treatment could lead to biased expectations or behaviors that might influence the outcomes. Maintaining a blind study requires that no one involved in the study, including the dog owners, have prior knowledge of the treatment allocation.
Conclusion
The correct answer, A, emphasizes the importance of maintaining a blind study design to eliminate bias. By ensuring that neither the researchers, dog owners, nor response gatherers know which dogs are receiving the medication or the placebo, the integrity of the experimental results is preserved. All other options fail to uphold the fundamental principle of a blind study, which is essential for obtaining valid and reliable data.